As of 2026-10-01, Eli Lilly (LLY) has an overall Hold technical signal, while Novo Nordisk (NVO) reads Sell. Over the last six months LLY returned +23.3% versus NVO at +2.4% (so LLY has outperformed on price). These are automated technical readings for education, not financial advice.
| Metric | LLY | NVO |
|---|---|---|
| Price | $1,149.85 | $37.40 |
| Daily change | -0.62% | -1.35% |
| Overall signal | Hold | Sell |
| Confidence | 30% | 65% |
| 6-month return | +23.3% | +2.4% |
| RSI (14) | 45 | 27 |
| MACD | Buy | Sell |
| Trend | Uptrend | Downtrend |
Eli Lilly full analysis · Novo Nordisk full analysis · Interactive chart →
⚠️ Not financial advice. Automated technical information for education only; indicators are not proven to beat buy-and-hold. © 2026 DailyTechnicals.